REFERENCES
- Dehner LP, Hill DA, Deschryver K. Pathology of the breast in children, adolescents, and young adults. Semin Diagn Pathol 1999; 16: 235–47.
- Ismail AA, Barth JH. Endocrinology of gynecomastia. Ann Clin Biochem 2001; 38: 596–607.
- Lazala C, Saenger P. Pubertal gynecomastia. J Pediatr Endocrinol Metab 2002; 15: 553–60.
- Donovan B, Bodsworth NJ, Mulhall BP, Allen D. Gynaecomastia associated with saquinavir therapy. Int J STD AIDS 1999; 10: 49–50.
- Peyriere H, Mauboussin JM, Rouanet I, et al. Report of gynecomastia in five male patients during antiretroviral thera-py for HIV infection. AIDS 1999; 13: 2167–9.
- Qazi N, Morlese J, King DM, Ahmad R, Nelson M. Diagnosis and management of male breast enlargement in patients with HIV/AIDS. AIDS Read 2000; 10: 703–8.
- Melbourne KM, Brown SL, Silverblatt FJ. Gynecomastia with stavudine treatment in an HIV-positive patient. Ann Pharmacother 1998; 32: 1108.
- Manfredi R, Calza L, Chiodo F. Gynecomastia associat-ed with highly active antiretroviral therapy. Ann Pharmacother 2001; 35: 438–9.
- Mercie P, Viallard JF, Thiebaut R, et al. Efavirenz-asso-ciated breast hypertrophy in HIV-infection patients. AIDS 2001; 15: 126–9.
- Paech V, Lorenzon T, Von Krosigk A, Graefe K, Stoehr A, Plettenberg A. Gynaecomastia in HIV-infected men: association with effects of antiretroviral therapy. AIDS 2002; 16: 1193–5.
- Pantanowitz L, Evans D, Gross PD, Dezube BJ. HIV-related gynecomastia. Breast J 2003; 9: 131–2.
- Caso JA, Prieto JM, Casas E, Sanz J. Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz. AIDS 2001; 15: 1447–8.
- Qazi NA, Morlese JF, King DM, Ahmad RS, Gazzard BC, Nelson MR. True gynaecomastia, another manifestation of immune reconstitution disease? Int J STD AIDS 2002; 13: 59–65.
- Galli M, Gervasoni C, Ridolfo AL, et al. Cytokine pro-duction in women with antiretroviral treatment-associated breast fat accumulation and limb wasting. AIDS 2003; 17 (Suppl. 1): S155-61.
- Piroth L, Grappin M, Petit JM, et al. Incidence of gynecomastia in men infected with HIV and treated with high-ly active antiretroviral therapy. Scand J Infect Dis 2001; 33: 559–60.
- McComsey G, Bhumbra N, Ma JF, Rathore M, Alvarez A. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study. Pediatrics 2003; 111: e275–81.
- Collazos J, Ibarra S, Martinez E, Mayo J. Serum pro-lactin concentrations in patients infected with human immun-odeficiency virus. HIV Clin Trials 2002; 3: 133–8.